2nd Subcommittee on children's medicines: Applications (Section 1-15)

• Section 16-29

Section 1: Anaesthetics

Section 2: Analgesics

Section 3: Antiallergics

Section 4: Antidotes

• Acetylcysteine (Review)
• Charcoal, activated (Review)
• Pralidoxime (Inclusion)

Section 5: Anticonvulsants/antiepileptics

Section 6: Anti-infective medicines

• Carbapenems (Review)
• Cefalexin (Inclusion)
• Ceftazidime (Review)
• Ceftriaxone (Review)
• Fluoroquinolones (Review)
• Gentamicin (Review)
• Lamivudine, nevirapine, zidovudine (New formulation)
• Lamivudine, stavudine, nevirapine (New formulation)
• Lamivudine, zidovudine (New formulation)
• Liposomal amphotericin B (Inclusion)
• Macrolides (Review)
• Procaine benzylpenicillin (Review)
• Sulfadiazine (Review)
• TB medicines (Review)
• Tetracycline (Review)

Section 7: Antimigraine medicines

Section 8: Antineoplastic

• Cytotoxic medicines (Review)
• Medicines used in palliative care (Inclusion)
• Methotrexate (Review)

Section 9: Antiparkinsonism medicines

Section 10. Medicines affecting the blood

Section 11: Blood products

Section 12: Cardiovascular medicines

• Quinidine (Review)
• Rheumatic Fever and Rheumatic Heart Disease (Review)

Section 13: Dermatological medicines

• Dermatological medicines (Review)

Section 14: Diagnostic agents

Section 15: Disinfectants

• Chlorhexidine (New formulation)